List of Tables
Table 1. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Dabrafenib
Table 3. Key Players of Trametinib
Table 4. Key Players of Lifirafenib
Table 5. Key Players of Others
Table 6. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Region (2020-2025)
Table 10. Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Region (2026-2031)
Table 12. Targeted Drug BRAF Inhibitors for NSCLC Market Trends
Table 13. Targeted Drug BRAF Inhibitors for NSCLC Market Drivers
Table 14. Targeted Drug BRAF Inhibitors for NSCLC Market Challenges
Table 15. Targeted Drug BRAF Inhibitors for NSCLC Market Restraints
Table 16. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Players (2020-2025)
Table 18. Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug BRAF Inhibitors for NSCLC as of 2024)
Table 19. Ranking of Global Top Targeted Drug BRAF Inhibitors for NSCLC Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Targeted Drug BRAF Inhibitors for NSCLC Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Targeted Drug BRAF Inhibitors for NSCLC, Headquarters and Area Served
Table 22. Global Key Players of Targeted Drug BRAF Inhibitors for NSCLC, Product and Application
Table 23. Global Key Players of Targeted Drug BRAF Inhibitors for NSCLC, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Market Share by Type (2020-2025)
Table 27. Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Market Share by Type (2026-2031)
Table 29. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Market Share by Application (2020-2025)
Table 31. Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Market Share by Application (2026-2031)
Table 33. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 48. BeiGene Company Details
Table 49. BeiGene Business Overview
Table 50. BeiGene Targeted Drug BRAF Inhibitors for NSCLC Product
Table 51. BeiGene Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2020-2025) & (US$ Million)
Table 52. BeiGene Recent Development
Table 53. Novartis Company Details
Table 54. Novartis Business Overview
Table 55. Novartis Targeted Drug BRAF Inhibitors for NSCLC Product
Table 56. Novartis Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2020-2025) & (US$ Million)
Table 57. Novartis Recent Development
Table 58. Research Programs/Design for This Report
Table 59. Key Data Information from Secondary Sources
Table 60. Key Data Information from Primary Sources
Table 61. Authors List of This Report
List of Figures
Figure 1. Targeted Drug BRAF Inhibitors for NSCLC Picture
Figure 2. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Type: 2024 VS 2031
Figure 4. Dabrafenib Features
Figure 5. Trametinib Features
Figure 6. Lifirafenib Features
Figure 7. Others Features
Figure 8. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application: 2024 VS 2031
Figure 10. Squamous Cell Carcinoma of NSCLC Case Studies
Figure 11. Adenocarcinoma of NSCLC Case Studies
Figure 12. Large Cell Carcinoma of NSCLC Case Studies
Figure 13. Targeted Drug BRAF Inhibitors for NSCLC Report Years Considered
Figure 14. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Targeted Drug BRAF Inhibitors for NSCLC Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Region: 2024 VS 2031
Figure 17. Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Players in 2024
Figure 18. Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug BRAF Inhibitors for NSCLC as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Targeted Drug BRAF Inhibitors for NSCLC Revenue in 2024
Figure 20. North America Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Targeted Drug BRAF Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 22. United States Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Targeted Drug BRAF Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 26. Germany Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Share by Region (2020-2031)
Figure 34. China Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 42. Mexico Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 46. Turkey Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Targeted Drug BRAF Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. BeiGene Revenue Growth Rate in Targeted Drug BRAF Inhibitors for NSCLC Business (2020-2025)
Figure 50. Novartis Revenue Growth Rate in Targeted Drug BRAF Inhibitors for NSCLC Business (2020-2025)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
